Breast Cancer News
In this section, access cutting-edge breast cancer news on treatment updates, emerging therapies, study results and other medical and quality-of-life issues important to you.
(Reuters) - U.S. health regulators approved a new drug made by Roche Holding AG for some patients with late-stage metastatic breast cancer who fail to respond to other therapies.
LONDON (Reuters) - In an unlikely tie-up, astronomers and cancer researchers have joined forces to study breast tumors using image analysis software originally developed to explore the distant stars.
NEW YORK (Reuters Health) - Women getting fertility treatments can be reassured that in vitro fertilization (IVF) does not increase their risk of breast and gynecological cancers, according to a new study of Israeli women.
CANBERRA (Reuters) - An Australian court ruled on Friday that two technology companies could hold a patent on genetic material related to cancer, in a case similar to one before the U.S. Supreme Court that has implications for gene-based medicine worldwide.
A study using the Oncotype DX test showed a relationship between Recurrence Score and chances of breast cancer recurrence and survival in women with estrogen receptor-positive breast cancer that traveled to the lymph nodes in and around the armpit (axillary lymph nodes) who were treated with hormonal therapy and chemotherapy.
NEW YORK (Reuters Health) - Screening women over 65 each year for breast cancer doesn't catch any more early tumors - but it does lead to more false positives - than screening every other year, according to a new study.
NEW YORK (Reuters Health) - A new look at real-world outcomes for women with early-stage breast cancer finds that breast-conserving surgery may offer survival odds that are as good, or even better, than breast removal.
NEW YORK (Reuters Health) - Women carrying BRCA mutations tied to breast and ovarian cancer may hit menopause a few years earlier than other women, according to a new study.
Research shows younger women given pre-surgical, or neoadjuvant, chemotherapy are more likely to have a complete response to that treatment than older women.
An article in the New England Journal of Medicine with updated overall survival results from the international EMILIA study of T-DM1 was published two days following an announcement of accelerated FDA review for the medicine.